Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | GLA | P06280 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 13/20 | 0.44 |
| ▸ | CA1 | P00915 | 12/20 | 0.44 |
| ▸ | CA9 | Q16790 | 9/20 | 0.38 |
| ▸ | CA12 | O43570 | 4/20 | 0.37 |
| ▸ | CA7 | P43166 | 4/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.37 |
| ▸ | CA3 | P07451 | 2/20 | 0.37 |
| ▸ | CA4 | P22748 | 2/20 | 0.37 |
| ▸ | CA6 | P23280 | 2/20 | 0.37 |
| ▸ | CA5A | P35218 | 2/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.35 |
| ▸ | MMP13 | P45452 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4427096 | 0.92 | TSHR (0.62) | RECQLTSHRGLAHPGDMAPK1 | |
| SCHEMBL2419707 | 0.85 | RECQL (0.75) | RECQLTSHRGLAHPGDMAPK1 | |
| SCHEMBL6338087 | 0.85 | RECQL (0.75) | RECQLTSHRGLAHPGDMAPK1 | |
| SCHEMBL1416798 | 0.85 | RECQL (0.69) | RECQLTSHRGLAHPGDMAPK1 | |
| SCHEMBL4423161 | 0.83 | RECQL (0.46) | RECQLTSHRGLAHPGDMAPK1 | |
| SCHEMBL17456497 | 0.82 | TSHR (0.75) | RECQLTSHRGLAHPGDMAPK1 | |
| Potassium Ion SCHEMBL6534824 | 0.82 | TSHR (0.75) | RECQLTSHRGLAHPGDMAPK1 | |
| Lithium Ion SCHEMBL17456624 | 0.82 | TSHR (0.75) | RECQLTSHRGLAHPGDMAPK1 | |
| SCHEMBL302087 | 0.82 | TSHR (0.83) | RECQLTSHRGLAHPGDMAPK1 | |
| SCHEMBL2634750 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7638636-B2 | Phosphonium and imidazolium salts and methods of their preparation | CYTEC TECHNOLOGY CORP. (US) | 2009-12-29 | — | — | US | claimed |
| EP-1587813-B1 | PHOSPHONIUM AND IMIDAZOLIUM SALTS AND METHODS OF THEIR PREPARATION | CYTEC CANADA INC (CA) | 2007-10-03 | — | — | EP | claimed |
| US-20060264645-A1 | Phosphonium and imidazolium salts and methods of their preparation | CYTEC CANADA INC. (CA) | 2006-11-23 | — | — | US | claimed |
| CN-1675230-A | Phosphonium and imidazolium salts and methods for their preparation | CYTEC CANADA INC (CA) | 2005-09-28 | — | — | CN | claimed |
| US-7638636-B2 | Phosphonium and imidazolium salts and methods of their preparation | CYTEC TECHNOLOGY CORP. (US) | 2009-12-29 | — | — | US | disclosed |
| EP-1587813-B1 | PHOSPHONIUM AND IMIDAZOLIUM SALTS AND METHODS OF THEIR PREPARATION | CYTEC CANADA INC (CA) | 2007-10-03 | — | — | EP | disclosed |
| US-20060264645-A1 | Phosphonium and imidazolium salts and methods of their preparation | CYTEC CANADA INC. (CA) | 2006-11-23 | — | — | US | disclosed |
| CN-1675230-A | Phosphonium and imidazolium salts and methods for their preparation | CYTEC CANADA INC (CA) | 2005-09-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264645-A1 | Phosphonium and imidazolium salts and methods of their preparation | PIK3R5, PHOSPHO1, PNISR | RECQL 140/4885TSHR 1922/4885GLA 4154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.